“We are going to evaluate how the commercialization of this substance fits in with our company product at Adastra in an effort to position ourselves to support the need for a secure source of copyright,” explained Main government officer Michael Forbes in the information launch. The corporate told VICE News it wouldn't be commenting further.CIP